Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Pfizer in Asia Will Focus on Asia-Specific Diseases and Solutions

publication date: Apr 7, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pfizer will turn the focus of its Singapore clinical research unit toward Asia-specific diseases. In part, this means the unit will emphasize diseases that are more prevalent in Asia, diseases such as specific forms of cancer. It also means that Pfizer will investigate diseases that are prevalent around the globe, but whose etiology in Asian populations may be different than in the rest of the world. Pfizer cited diabetes as an example of the latter category. More details...

Stock Symbol: (NYSE: PFE)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...